WELCOME TO THE ADD-ASPIRIN WEBSITE

This website is designed to provide information about the Add-Aspirin Trial, both for people taking part in the trial (participants) and collaborators. Please use the menus at the top of the screen to find out more about the trial.           

Add-Aspirin is a large randomised clinical trial, which is taking place in the UK and India. It will recruit 11,000 participants to help find out whether regular aspirin use after treatment for an early stage cancer can prevent the cancer from coming back and preventing deaths.

Congratulations to our top 5 recruiting centres:
1. Worcestershire Royal Hospital
2. University Hospitals Coventry & Warwickshire
3. Bristol Haematology & Oncology Centre
4. Royal Marsden Hospitals
5. Churchill Hospital, Oxford


*FOR GENERAL AND CLINICAL QUERIES, PLEASE CHECK OUR
FAQs*

NEWS

24th March 2017

Substantial Amendment:
Protocol v5.0 Launch


Add-Aspirin is pleased to formally notify sites of the Substantial Amendment for Protocol v5.0. From 24th March 2017 all sites can continue to work on Protocol v4 and supporting documents but will be expected by 21st April 2017 to submit the amendment documentation to mrcctu.add-aspirin@ucl.ac.uk.


Read more

Quick links for
NHS professionals


REGISTER A PARTICIPANT

To RANDOMISE a participant please call +44 (0)20 7670 4777

UNBLIND A PARTICIPANT

 

BREAST


We aim to recruit 3100 individuals who have had surgery to remove an early stage breast cancer. 

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here   

Top recruiters: Royal Marsden Hospitals, Worcestershire Royal Hospital, Addenbrookes, Churchill Hospital Oxford

PARTICIPANTS REGISTERED: 1214
PARTICIPANTS RANDOMISED: 864   

COLON/RECTUM 


We aim to to recruit 2600 individuals who have had surgery to remove an early stage bowel cancer. 

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here 

Top recruiters: Bristol Haematology & Oncology Centre, Worcestershire Royal Hospital, St James 's University Hospital

PARTICIPANTS REGISTERED: 643
PARTICIPANTS RANDOMISED: 471

STOMACH/OESOPHAGUS 


We aim to recruit 2100 individuals who have had surgery or a combination of chemotherapy and radiotherapy to treat a cancer of the stomach or oesophagus (food pipe).

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here

Top recruiters: Leicester Royal Infirmary, The Christie, St James's University Hospital

PARTICIPANTS REGISTERED: 78
PARTICIPANTS RANDOMISED: 52

PROSTATE


We aim to recruit 2120 individuals who have had surgery or radiotherapy to treat an early stage prostate cancer. 

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here    

Top recruiters: Bristol Haematology & Oncology Centre, UCHW, University Hospital of Wales
                                             PARTICIPANTS REGISTERED: 506
PARTICIPANTS RANDOMISED: 371
     

The trial is being jointly funded by Cancer Research UK (grant number C471 /A15015, www.cancerresearchuk.org), the National Institute for Health Research Health Technology Assessment Programme (project number 12/01/38, www.nihr.ac.uk) and the MRC Clinical Trials Unit at UCL.
© Add-Aspirin, MRC CTU at UCL cookies